Eiko LifeSciences Limited (BOM:540204)

India · Delayed Price · Currency is INR

48.43

-0.47 (-0.96%)

At close: Jul 31, 2026

Eiko LifeSciences Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	527.07	527.07	376.64	279.29	183.21	254.12
Revenue Growth	39.94%	39.94%	34.85%	52.44%	-27.90%	111.93%
Gross Profit	114.11	114.11	48.59	25.14	22.07	27.96
Operating Income	64.22	64.22	20.23	9.5	3.22	7.53
Net Income	44.96	44.96	21.06	7.52	7.69	7.06
Earnings Per Share	3.19	3.19	1.62	0.73	0.79	0.90
EPS Growth	97.49%	97.49%	121.73%	-7.26%	-12.72%	-44.03%

Revenue by Segment

Fiscal Year	TTM	FY 2026
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026
Speciality Chemicals & Pharma Intermediates	460.28	460.28
Logistics Services	66.79	66.79
Total	527.07	527.07

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	136.14	136.14	117.81	133.46	6.12	2.17
Total Debt	47.3	47.3	27.63	-	0.54	46.28
Net Cash (Debt)	88.84	88.84	90.17	133.46	5.59	-44.1
Net Cash Growth	-1.48%	-1.48%	-32.44%	2288.33%	-	-
Net Cash Per Share	6.30	6.30	6.92	12.94	0.57	-5.65

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	22.84	22.84	29.24	-70.8	42.24	-77.27
Capital Expenditures	-	-	-102.91	-3.47	-2.25	-1.55
Free Cash Flow	22.84	22.84	-73.67	-74.26	39.99	-78.82
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	21.65%	21.65%	12.90%	9.00%	12.05%	11.00%
Operating Margin	12.18%	12.18%	5.37%	3.40%	1.76%	2.96%
Pretax Margin	13.50%	13.50%	8.14%	3.52%	5.60%	3.71%
Profit Margin	8.53%	8.53%	5.59%	2.69%	4.20%	2.78%
FCF Margin	4.33%	4.33%	-19.56%	-26.59%	21.83%	-31.02%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 3, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	15.18	16.77	31.99	95.35	82.68	57.15
P/FCF Ratio	30.42	33.02	-	-	15.89	-
PS Ratio	1.32	1.43	1.79	2.57	3.47	1.59